1CP-LSD (1-cyclopropanoyl-LSD) is a novel lysergamide that became available commercially for the first time in 2019. It is the N-cyclopropanoyl amide of LSD itself. Furthermore, It resembles the indole prodrug structure of 1P-LSD and ALD-52. Each blotter contains 100 mcg of the compound. It is NOT intended for human consumption, and is strictly for laboratory reagent or forensic analysis purposes ONLY. It is available only as the hemi-tartrate salt.